News Articles

Virpax® Pharmaceuticals Announces Closing of $40 Million Public Offering of Common Stock BERWYN, Pa. -Saturday 18 September 2021

(BUSINESS WIRE) -- Virpax® Pharmaceuticals Inc. (“Virpax” or the “Company”) (NASDAQ:VRPX), a company specializing in developing pharmaceutical products for pain management, today announced the closing of an underwritten public offering of 6,670,000 shares of its common stock at a...

Virpax® Pharmaceuticals Announces Pricing of $40 Million Public Offering of Common Stock -Wednesday 15 September 2021

(BUSINESS WIRE)-- Virpax® Pharmaceuticals Inc. (“Virpax” or the “Company”) (NASDAQ:VRPX), a company specializing in developing pharmaceutical products for pain management, today announced the pricing of an underwritten public offering of 6,670,000 shares of its common stock at a...